Farms.com Home   News

Join us at the 2024 National Soy Research Conference

Register today!

If you’re involved in researching, breeding, commercializing, or funding work on soybeans in Canada you won’t want to miss the 2024 National Soy Research Conference.

Join your colleagues at this unique event bringing together leading experts from across the Canadian private, public and grower soybean community to hear the latest on the big issues affecting soybeans. We’ll be shaping the future with an agenda covering what end use quality means for seed development, how climate stress tolerance is advancing and what disease and agronomic trends mean for research and seed development.

We’re excited about an event that will give you the information you need to make the best decisions about future work on Canadian soy.

Details to remember:
Date: 9am-5pm, January 24th 2024
Place: Four Points Sheraton, London ON

Please find the agenda and registration details here, at our event page.

Source : Soycanada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.